JANE STREET GROUP, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,185,630
+258.3%
662,363
+580.5%
0.00%
Q4 2022$330,943
+308.6%
97,336
+559.1%
0.00%
Q3 2022$81,000
-91.4%
14,768
-92.9%
0.00%
Q2 2022$941,000
-81.8%
208,597
-70.3%
0.00%
-100.0%
Q1 2022$5,169,000
+123.2%
701,443
+94.8%
0.00%
Q4 2021$2,316,000
+442.4%
360,143
+391.1%
0.00%
Q3 2021$427,000
-35.4%
73,328
+14.5%
0.00%
Q2 2021$661,000
-46.4%
64,042
-45.4%
0.00%
Q1 2021$1,233,000
-59.4%
117,225
-40.3%
0.00%
-100.0%
Q4 2020$3,039,000
+50.5%
196,358
+42.0%
0.00%
+100.0%
Q3 2020$2,019,000
-63.0%
138,325
-52.0%
0.00%
-80.0%
Q2 2020$5,457,000
+111.7%
288,119
+114.7%
0.01%
+66.7%
Q1 2020$2,578,000
+801.4%
134,200
+798.4%
0.00%
Q4 2019$286,000
+38.8%
14,937
-30.3%
0.00%
Q3 2019$206,000
-68.7%
21,423
+51.6%
0.00%
-100.0%
Q2 2014$658,00014,1320.01%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$35,031,00023.03%
Palo Alto Investors LP 5,267,652$81,543,0004.28%
Fairmount Funds Management LLC 702,351$10,872,0003.89%
Birchview Capital, LP 188,000$2,910,0001.68%
Mesirow Financial Investment Management, Inc. 22,303$345,250,0001.09%
EMERALD ADVISERS, LLC 1,822,781$28,217,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 1,661,236$25,716,0000.90%
RICE HALL JAMES & ASSOCIATES, LLC 1,552,504$24,033,0000.85%
Altium Capital Management LP 133,951$2,074,0000.77%
Hood River Capital Management LLC 931,754$14,424,0000.48%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders